Clinics in Dermatology
Volume 25, Issue 1 , Pages 19-25 , January 2007

Impaired wound healing

  • Nathan B. Menke, MD

      Affiliations

    • Department of Emergency Medicine, VCU Reanimation, Engineering and Shock Center, Virginia Commonwealth University Medical Center, Richmond, VA 23298-0614, USA
    • Department of Biochemistry, VCU Reanimation, Engineering and Shock Center, Virginia Commonwealth University Medical Center, Richmond, VA 23298-0614, USA
    • ,
  • Kevin R. Ward, MD

      Affiliations

    • Department of Emergency Medicine, VCU Reanimation, Engineering and Shock Center, Virginia Commonwealth University Medical Center, Richmond, VA 23298-0614, USA
    • Department of Biochemistry, VCU Reanimation, Engineering and Shock Center, Virginia Commonwealth University Medical Center, Richmond, VA 23298-0614, USA
    • ,
  • Tarynn M. Witten, PhD

      Affiliations

    • Center for the Study of Biological Complexity, VCU Reanimation, Engineering and Shock Center, Virginia Commonwealth University, Richmond, VA 23284-2030, USA
    • Department of Mathematics, VCU Reanimation, Engineering and Shock Center, Virginia Commonwealth University, Richmond, VA 23284-2014, USA
    • ,
  • Danail G. Bonchev, PhD

      Affiliations

    • Center for the Study of Biological Complexity, VCU Reanimation, Engineering and Shock Center, Virginia Commonwealth University, Richmond, VA 23284-2030, USA
    • Department of Mathematics, VCU Reanimation, Engineering and Shock Center, Virginia Commonwealth University, Richmond, VA 23284-2014, USA
    • ,
  • Robert F. Diegelmann, PhD

      Affiliations

    • Department of Emergency Medicine, VCU Reanimation, Engineering and Shock Center, Virginia Commonwealth University Medical Center, Richmond, VA 23298-0614, USA
    • Department of Biochemistry, VCU Reanimation, Engineering and Shock Center, Virginia Commonwealth University Medical Center, Richmond, VA 23298-0614, USA
    • Corresponding Author InformationCorresponding author. Department of Biochemistry, Virginia Commonwealth University Medical Center, Richmond, VA 23298-0614, USA.

References 

  1. Lazarus GS, Cooper DM, Knighton DR, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol. 1994;130:489–493
  2. Nwomeh BC, Yager DR, Cohen IK. Physiology of the chronic wound. Clin Plast Surg. 1998;25:341–356
  3. Brem H, Balledux J, Bloom T, et al. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalents. Arch Surg. 2000;135:627–634
  4. Nelzen O, Bergqvist D, Lindhagen A, et al. Chronic leg ulcers: an underestimated problem in primary health care among elderly patients. Epidemiol Community Health. 1991;5:184–191
  5. Eltorai IM, Montroy RE, Kobayashi M, et al. Marjolin's ulcer in patients with spinal cord injury. J Spinal Cord Med. 2002;25:191–196
  6. Chraibi H, Dereure O, Teot L, et al. The diagnosis and treatment of carcinomas occurring at the sites of chronic pressure ulcers. J Wound Care. 2004;13:447–448
  7. CDC, National Diabetes Fact Sheet: National Estimates and General Information on Diabetes in the United States. 1998, US Dept of Health and Human Services, Centers for Disease Control and Prevention. Atlanta, GA.
  8. Diegelmann RF. Excessive neutrophils characterize chronic pressure ulcers. Wound Repair Regen. 2003;11:490–495
  9. Palolahti M, Lauharanta J, Stephens RW, et al. Proteolytic activity in leg ulcer exudate. Exp Dermatol. 1993;2:29–37
  10. Piaggesi A, Viacava P, Rizzo L, et al. Semiquantitative analysis of the histopathological features of the neuropathic foot ulcer: effects of pressure relief. Diabetes Care. 2003;26:3123–3128
  11. Lobmann R, Schultz G, Lehnert H. Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care. 2005;28:461–471
  12. Nwomeh BC, Liang HX, Cohen IK, et al. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J Surg Res. 1999;81:189–195
  13. Nwomeh BC, Liang HX, Diegelmann RF, et al. Dynamics of the matrix metalloproteinases MMP-1 and MMP-8 in acute open human dermal wounds. Wound Repair Regen. 1998;6:127–134
  14. Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol. 1993;101:64–68
  15. Yager DR, Zhang LY, Liang HX, et al. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol. 1996;107:743–748
  16. Lobmann R, Ambrosch A, Schultz G, et al. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia. 2002;45:1011–1016
  17. Bullen EC, Longaker MT, Updike DL, et al. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol. 1995;104:236–240
  18. Mast B, Schultz G. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen. 1996;4:420–441
  19. Cooper DM, Yu EZ, Hennessey P, et al. Determination of endogenous cytokines in chronic wounds. Ann Surg. 1994;219:688–691[discussion 691-2]
  20. Falanga V. Growth factors and chronic wounds: the need to understand the microenvironment. J Dermatol. 1992;19:667–672
  21. Bennett NT, Schultz GS. Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am J Surg. 1993;166:74–81
  22. Brem H, Stojadinovic O, Diegelmann R, et al. Molecular markers of surgical debridement in patients with chronic wounds indentify healing edges. J Mol Med. 2007;(In press)
  23. Robson MC, Hill DP, Woodske ME, et al. Wound healing trajectories as predictors of effectiveness of therapeutic agents. Arch Surg. 2000;135:773–777
  24. Steed DL. Wound-healing trajectories. Surg Clin North Am. 2003;83:547–555[vi-vii]
  25. Yager DR, Chen SM, Ward S, Olutoye OO, Diegelmann RF, Cohen IK. The ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Repair Regen. 1997;5:23–32
  26. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 1989;320:365–376
  27. Rao CN, Ladin DA, Liu YY, et al. Alpha 1–antitrypsin is degraded and nonfunctional in chronic wounds but intact and functional in acute wounds: the inhibitor protects fibronectin from degradation by chronic wound fluid enzymes. J Invest Dermatol. 1995;105:572–578
  28. Grinnell F, Zhu M. Fibronectin degradation in chronic wounds depends on the relative levels of elastase, alpha1-proteinase inhibitor, and alpha2-macroglobulin. J Invest Dermatol. 1996;106:335–341
  29. Suomalainen K, Halinen S, Ingman T, et al. Tetracycline inhibition identifies the cellular sources of collagenase in gingival crevicular fluid in different forms of periodontal diseases. Drugs Exp Clin Res. 1992;18:99–104
  30. Thompson RW, Baxter BT. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial. Ann N Y Acad Sci. 1999;878:159–178
  31. Curci JA, Petrinec D, Liao S, et al. Pharmacologic suppression of experimental abdominal aortic aneurysms: a comparison of doxycycline and four chemically modified tetracyclines. J Vasc Surg. 1998;28:1082–1093
  32. Greenwald RA, Moak SA, Ramamurthy NS, et al. Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage. J Rheumatol. 1992;19:927–938
  33. Maintzer M. Thinking in complexity: the complex dynamics of matter mind and mankind. Berlin, Germany: Springer-Verlag Berlin; 1996;
  34. Bar-Yam Ye. Unifying themes in complex systems. Cambridge (MA): Perseus Books; 2000;
  35. Witten TM. A note on the structure of system state spaces and its implications on the existence of non-repeatable experiments. Bull Math Biol. 1980;42:267–272
  36. In:  Gurel O,  Rossler OE editor. Bifurcation theory and it's applications in scientific disciplines. New York, (NY): New York Academy of Sciences Press; 1979;p. 408–466
  37. Wiggins S. Global bifurcations and chaos: analytical methods. New York (NY): Springer-Verlag Press; 1980;
  38. In:  Cherbit G editors. Fractals: non-integral dimensions and applications. Chichester, England: John Wiley & Sons; 1991;
  39. Moon FC. Chaotic and fractal dynamics: an introduction for applied scientists and engineers. New York (NY): John Wiley & Sons; 1992;
  40. Ebeling W, Peschel M, Weidlich W. Models of selforganization in complex systems. Berlin, Germany: Akademie Verlag GMBH; 1992;
  41. Bonchev DG, Rouvray DHE. Complexity in chemistry, biology, and ecology. New York (NY): Springer; 2005;
  42. Witten TM. Mathematical and computational tools for gerontologic research. In:  Yu BP editors. Handbook of aging research methods. Boca Raton (FL): CRC Press; 1998;
  43. Jensen HJ. Self-organized criticality: emergent complex behavior in physical and biological systems. Cambridge, England: Cambridge University Press; 1998;
  44. Witten TM. A return to time, cells, systems and aging: III. Critical elements, hierarchies, and Gompertzian dynamics. Mech Ageing Dev. 1985;32:141–177
  45. Bonchav D. Complexity of protein-protein interaction networks, complexes and pathways. In:  Conn M editors. Handbook of proteomics methods. New York: Humana Press; 2003;p. 451–462

PII: S0738-081X(06)00182-9

doi: 10.1016/j.clindermatol.2006.12.005

Clinics in Dermatology
Volume 25, Issue 1 , Pages 19-25 , January 2007

Article Tools

* Image Usage & Resolution